Exascale Labs Holdings Inc.
XLAB
Last
$0.97
Day
-2.6%
1y
-89.8%
5y
-89.7%
52w
-90.9%
SPY YTD
+13.3%
XLK
+37.1%
Earnings
—
EMA 21
2.22
EMA 50
3.93
EMA 200
7.55
20d high
-73.5%
5y high
-90.9%
5y range
1th
Positions held
Your positionsXLAB isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$1.64
Stop
$0.50
Stop distance
48.7%
Target vs last
+68.4%
Fundamentals
| Market cap | $65.62M | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | 0.00% |
| Revenue growth | 67.8% | Earnings growth | — | Gross margin | 16.3% | Operating margin | -46.5% |
| Profit margin | -82.1% | ROE | — | ROA | -42.7% | Debt / equity | — |
| Current ratio | 0.21 | Free cash flow | — | Analyst recommendation | none | Mean target | — |
| 52w high | $11.17 | 52w low | $0.94 |
Quarterly
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|
| Revenue | $3.8M | $3.5M | $2.5M | $1.9M |
| Op margin | -32.5% | -27.9% | -22.9% | -34.7% |
| Net income | -$2.6M | -$3.8M | -$1.5M | -$1.5M |
| Gross margin | 15.6% | 14.7% | 18.0% | 11.4% |
| Gross profit | $0.6M | $0.5M | $0.5M | $0.2M |
| Operating income | -$1.2M | -$1.0M | -$0.6M | -$0.6M |
- Revenue +6% vs prior quarter ($3.8M vs $3.5M).
- Gross margin 15.6% (was 14.7% prior quarter).
- Operating margin compressed to -32.5%.
Yearly (6y)
| 2025 | 2024 | |
|---|---|---|
| Revenue | $7.0M | $1.3M |
| Op margin | -43.4% | -139.9% |
| Net income | -$7.7M | -$5.0M |
| Gross margin | 15.8% | 4.2% |
| Gross profit | $1.1M | $0.1M |
| Operating income | -$3.0M | -$1.8M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsXLAB · daily-62.8% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin